The Effect of Bombesin, Cholecystokinin, Gastrin, and Their Antagonists on Proliferation of Pancreatic Cancer Cell Lines

References

• Johnson LR Physiology of the gastrointestinal tract. New York: Raven; 1994.
   Google Scholar
• Huang S-C, Fortune KP, Wank SA, Kopin AS, Gardner JD. Multiple affinity states of different cholecystokinin receptors. J Biol Chem 1994;269:26121–6.
   Google Scholar
• Jensen RT, Qian JM, Lin JT, Mantey SA, Pisegna JR, Wank SA. Distinguishing multiple CCK receptor subtypes. Studies with guinea pig chief cells and transfected human CCK receptor. Ann NY Acad Sci 1994;713:88–106.
   Google Scholar
• Zhou W, Povosoki SP, Rosen NA, Longnecker DS, Bell RH Jr. Characterization of cholecystokinin receptors in rat pancreas. Ann NY Acad Sci 1994;713:331–3.
   PubMedGoogle Scholar
• Ohlsson B, Axelson J, Sternby B, Rehfeld JF, Ihse I. Time- course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor. Int J Pancreatol 1995;18:59–66.
   Google Scholar
• Monstein H-J, Nylander A-G, Salehi A, Chen D, Lundquist I, Håkansson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. Scand J Gastroenterol 1996;31:383–90.
   Google Scholar
• Smith JP, Liu G, Soundararajan V, McLaughlin PJ, Zagon IS. Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. Am J Physiol 1994;266:R277–83.
   Google Scholar
• Smith JP, Rickabaugh CA, McLaughlin PJ, Zagon IS. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Am J Physiol 1993;265:G149–55.
   Google Scholar
• Iwase K, Evers BM, Hellmich MR, Gou Y-S, Higashide S, Kim HJ, et al. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology 1997;113:782–90.
   Google Scholar
• Hoosein NM, Kiener PA, Curry RC, Rovati LC, McGilbra DK, Brattain MG. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res 1998;48:7179–83.
   Google Scholar
• Smith JP, Solomon TE, Bagheri S, Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci 1990;35:1377–84.
   PubMedGoogle Scholar
• Smith JP, Kramer ST, Solomon TE. CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium. Reg Pep 1991;32:341–9.
   Google Scholar
• Smith Jp, Fantaskey AP, Liu G, Zagon IS. Identification of gastrin as a growth peptide in human pancreatic cancer. Am J Physiol 1995;268:R135–41.
   Google Scholar
• Abbruzzese JL, Gholson CF, Daugherty K, Larson E, DuBrow R, Berlin R, et al. A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer. Pancreas 1992;7:165–71.
   PubMedGoogle Scholar
• Shivaram S, Crist KA, Chaudhuri B, Mucci SJ, Chauduri PK. Effect of CCK receptor antagonist on growth of pancreatic adenocarcinoma. J Surg Res 1992;53:234–7.
   Google Scholar
• Walsh JH. Bombesin/GRP peptides. In: Martin JB, Brownstein MJ, Kriegar DT, editors. Brain peptides update. New York: John Wiley; 1987. p. 193–214.
   Google Scholar
• Lhoste E, Aprahamian M, Pousse A, Hoeltzel A, Stock-Damge C. Combined effect of chronic bombesin and secretin or cholecystokinin on the rat pancreas. Peptides 1985;6:83–7.
   Google Scholar
• Hajri A, Balboni G, Koenig M, Garaud JC, Damage C. Gastrinreleasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma. Cancer Res 1992;52:3726–32.
   Google Scholar
• Hajri A, Koenig M, Balboni G, Damgé C. Expression and characterization of gastrin-releasing peptide receptor in normal and cancerous pancreas. Pancreas 1996;12:25–35.
   Google Scholar
• Scudiero D, Schoemaker R, Paull K, Monks A, Tierney S, Nofziger T, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988;48:4827–33.
   PubMed Web of Science ®Google Scholar
• Song I, Brown DR, Wiltshire RN, Gantz I, Trent JM, Yamada T. The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc Natl Acad Sci USA 1993;90:9085–9.
   PubMed Web of Science ®Google Scholar
• Monstein H-J, Nilsson I, Ellnebo-Svedlund K, Svensson SPS. Cloning and characterization of 5′-end alternatively spliced human cholecystokinin-B receptor mRNAs. Recept Channels 1998;6: 165–77.
   Google Scholar
• Powers RE, Grady T, Orchard JL, Gilrane TB. Different effects of hyperstimulation by similiar classes of secretagogues on the exocrine pancreas. Pancreas 1993;8:58–63.
   PubMedGoogle Scholar
• Thumwood CM, Hong J, Baldwin GS. Inhibition of cell proliferation by the cholecystokinin antagonist L-364,718. Exp Cell Res 1990;186: 15–21.
   Google Scholar
• Smith JP, Kramer S, Bagheri S. Effects of a high-fat diet and L-364,718 on growth of human pancreas cancer. Dig Dis Sci 1990;35: 726–32.
   Google Scholar
• Cantor P, Mortensen PE, Myhre J, Gjorup I, Worning H, Stahl E, et al. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans. Gastroenterology 1992;102:1742–51.
   PubMed Web of Science ®Google Scholar
• Ohlsson B, Borg K, Rehfeld JF, Ihse I, Axelson J. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas. Int J Pancreatol. 1998;24: 211–8.
   Google Scholar
• Blackmore M, Hirst BH. Autocrine stimulation of growth of AR4–2J rat pancreatic tumour cells by gastrin. Br J Cancer 1992;66:32–8.
   PubMed Web of Science ®Google Scholar
• Smith JP, Shih A, Wu Y, McLaughlin PJ, Zagon IS. Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. Am J Physiol 1996;270:R1078–84.
   Google Scholar